Akinori Hashiguchi

Akinori Hashiguchi

Auto-generated profile, based on publicly available information

Akinori Hashiguchi

Department of Pathology, Keio University School of Medicine, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Internal Medicine
Verified
Journal Article
Open access
PDF file
YSYusuke Sakamaki
Yusuke Sakamaki
MHMatsuhiko Hayashi
Matsuhiko Hayashi
SWShu Wakino
Shu Wakino
SFSeiichi Fukuda
Seiichi Fukuda
KKKounosuke Konishi
Kounosuke Konishi
Hiroshi ItohHiroshi Itoh
Hiroshi Itoh
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

1 January 2013 in Magnetic Resonance in Medical Sciences
Verified
Journal Article
Open access
PDF file
KOKei Osugi
Kei Osugi
ATAkihiro Tanimoto
Akihiro Tanimoto
JNJun Nakashima
Jun Nakashima
KSKazunobu Shinoda
Kazunobu Shinoda
AHAkinori Hashiguchi
Akinori Hashiguchi
SKSachio Kuribayashi
Sachio Kuribayashi
Purpose: We aimed to determine which of the following magnetic resonance (MR) imaging sequences is most effective for detecting prostate cancer: T2-weighted (T2W), dynamic contrast-enhanced (DCE) T1-weighted (T1W), or diffusion-weighted (DWI) imaging or apparent diffusion coefficient (ADC) mapping. Materials and Methods: We included 37 male patients with prostate cancer who underwent MR imaging before radical prostatectomy in this retrospective study. Sixty-four foci (>5 mm in size; 35 in the peripheral zone [PZ], 29 in the transitional zone [TZ]) were histopathologically determined to be prostate cancer. We determined the capacity of T2W, DCE-T1W, DWI, ADC mapping alone, and the combination of ADC mapping with DWI, and conventional MR sequences to detect prostate cancer, including their sensitivity and positive predictive value (PPV), with reference to the results obtained in histopathological examinations of whole-mount sections. Results: In the PZ, sensitivities were 31.4% (T2W), 37.1% (DCE-T1W), 51.4% (DWI), and 71.4% (ADC mapping); PPVs were 78.6% (T2W), 92.9% (DCE-T1W), 94.7% (DWI), and 96.0% (ADC mapping). Sensitivity was significantly higher of ADC mapping than other sequences. In the TZ, sensitivities were 55.1% (T2W), 44.8% (DCE-T1W), 82.8% (DWI), and 89.7% (ADC mapping); PPVs were 64.0% (T2W), 46.4% (DCE-T1W), 70.6% (DWI), and 72.2% (ADC mapping). Sensitivity was significantly higher of ADC mapping and DWI than conventional MR imaging, but there was no significant correlation between DWI/ADC mapping and T2W/DCE-T1W with respect to PPVs. Combining sequences did not improve sensitivity; only the PPV in the TZ improved when ADC mapping was combined with DCE-T1W. Conclusion: ADC mapping is the most effective standard MR imaging tool for detecting prostate cancer. The addition of DCE-T1W may improve the PPV of ADC mapping for diagnosing cancer in the TZ.

28 April 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
ENErina Sugita Nishimura
Erina Sugita Nishimura
AHAkihito Hishikawa
Akihito Hishikawa
RNRan Nakamichi
Ran Nakamichi
RARiki Akashio
Riki Akashio
SCShunsuke Chikuma
Shunsuke Chikuma
KHKaori Hayashi
Kaori Hayashi
DNA damage repair is a critical physiological process closely linked to aging. The accumulation of DNA damage in renal proximal tubular epithelial cells (PTEC) is related to a decline in kidney function. Here, we report that DNA double-strand breaks in PTECs lead to systemic metabolic dysfunction, including weight loss, reduced fat mass, impaired glucose tolerance with mitochondrial dysfunction, and increased inflammation in adipose tissues and the liver. Single-cell RNA sequencing analysis reveals expansion of CD11c+ Ccr2+ macrophages in the kidney cortex, liver, and adipose tissues and Ly6Chi monocytes in peripheral blood. DNA damage in PTECs is associated with hypomethylation of macrophage activation genes, including Gasdermin D, in peripheral blood cells, which is linked to reduced DNA methylation at KLF9-binding motifs. Macrophage depletion ameliorates metabolic abnormalities. These findings highlight the impact of kidney DNA damage on systemic metabolic homeostasis, revealing a kidney-blood-metabolism axis mediated by epigenetic changes in macrophages.

16 September 2021 in CEN Case Reports
Verified
Journal Article
Open access
PDF file
KAKeika Adachi
Keika Adachi
HTHirobumi Tokuyama
Hirobumi Tokuyama
YOYoichi Oshima
Yoichi Oshima
TITomoaki Itoh
Tomoaki Itoh
AHAkinori Hashiguchi
Akinori Hashiguchi
Hiroshi ItohHiroshi Itoh
Hiroshi Itoh
Fabry disease (FD) is an X-linked genetic lysosomal disorder caused by alpha-galactosidase A (GLA) deficiency. Multiple myeloma (MM) predominately affects older adults, which ranks as the second commonest hematological malignancy. Their overlap has rarely been reported. We present a case of the coexistence of FD and MM in a patient. We report the case of a 68-year-old woman who was referred to our hospital for the evaluation of thoracic spine tumor with bone destruction. On admission, her serum creatinine (Cr) level was elevated to 12.70 mg/dL from the baseline value of 0.91 mg/dL. Bone marrow aspiration revealed MM. Renal biopsy showed myeloma cast nephropathy, which was the primary cause of acute kidney injury. Renal pathology also showed podocyte swelling and tubule myeloid bodies in a mosaic pattern compatible with female FD. Consequently, the patient was diagnosed as FD based on the germ line mutation in GLA. The patient was treated with bortezomib and dexamethasone therapy, which significantly improved the renal function. This is the second case demonstrating a potential pathogenic relationship between FD and MM. Since FD is one of the few genetic diseases for which there are therapeutic agents with fewer side effects, diagnostic value of FD is high. If an MM patient has multiple organ abnormalities or any familial history, the physician should suspect FD.

11 August 2021 in Oral and Maxillofacial Surgery Cases
Verified
Journal Article
Open access
SASeiji Asoda
Seiji Asoda
MMMayu Morita
Mayu Morita
TSTomoya Soma
Tomoya Soma
HSHitoshi Sato
Hitoshi Sato
THToshihiro Hasegawa
Toshihiro Hasegawa
HKHiromasa Kawana
Hiromasa Kawana
We herein report a rare case of undifferentiated carcinoma that originated in the mandible with the same pathological findings as seen in the liver. A 64-year-old man underwent surgery for a hepatic tumor in October 2006, and the pathological diagnosis was undifferentiated carcinoma. The patient was referred to our department in January 2007, when whole-body positron emission tomography/computed tomography showed the uptake of fluorodeoxyglucose in the right mandibular ramus. The patient underwent right hemimandibulectomy in April 2007. The resected tumor was also undifferentiated carcinoma. In May 2014, seven years after the lower mandibular operation, the tumor recurred at the site corresponding to the right mandibular ramus after resection, and tumor resection and right neck dissection were performed. As a result of the histopathological examination, the undifferentiated carcinoma findings were the same as before. There have been no signs of local recurrence or metastases for over six years since the second mandibular surgery.

21 March 2024 in Clinical Genitourinary Cancer
Verified
Journal Article
Closed access
KMKazuhiro Matsumoto
Kazuhiro Matsumoto
HAHirotaka Akita
Hirotaka Akita
AHAkinori Hashiguchi
Akinori Hashiguchi
TTToshikazu Takeda
Toshikazu Takeda
TKTakeo Kosaka
Takeo Kosaka
MJMasahiro Jinzaki
Masahiro Jinzaki